Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 8c

February 15, 2017 4:05 PM EST
Get Alerts VNDA Hot Sheet
Price: $5.22 --0%

Financial Fact:
Net income (loss): -430K

Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.01), $0.08 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.24 million versus the consensus estimate of $38.39 million.

For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings